| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Risperidone in children with autism and serious behavioral problems.
|
N Engl J Med
|
2002
|
9.35
|
|
2
|
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
6.71
|
|
3
|
Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective.
|
Biol Psychiatry
|
2013
|
3.47
|
|
4
|
3-year follow-up of the NIMH MTA study.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
3.33
|
|
5
|
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
|
Am J Psychiatry
|
2005
|
2.94
|
|
6
|
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
2.13
|
|
7
|
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
2.03
|
|
8
|
What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?
|
J Consult Clin Psychol
|
2005
|
2.03
|
|
9
|
Which treatment for whom for ADHD? Moderators of treatment response in the MTA.
|
J Consult Clin Psychol
|
2003
|
2.02
|
|
10
|
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
|
J Abnorm Child Psychol
|
2007
|
1.98
|
|
11
|
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.98
|
|
12
|
Risperidone and adaptive behavior in children with autism.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
1.71
|
|
13
|
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.
|
J Clin Psychiatry
|
2008
|
1.70
|
|
14
|
A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment.
|
BMC Med
|
2012
|
1.67
|
|
15
|
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.
|
J Clin Psychiatry
|
2010
|
1.67
|
|
16
|
Validity of the autism diagnostic interview-revised.
|
Am J Ment Retard
|
2006
|
1.66
|
|
17
|
The services for children and adolescents-parent interview: development and performance characteristics.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.64
|
|
18
|
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
1.61
|
|
19
|
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.
|
J Am Acad Child Adolesc Psychiatry
|
2009
|
1.55
|
|
20
|
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
1.48
|
|
21
|
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.
|
J Clin Psychiatry
|
2010
|
1.47
|
|
22
|
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
|
J Autism Dev Disord
|
2008
|
1.46
|
|
23
|
Self-perceptions of competence in children with ADHD and comparison children.
|
J Consult Clin Psychol
|
2004
|
1.43
|
|
24
|
Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder.
|
J Clin Child Adolesc Psychol
|
2005
|
1.41
|
|
25
|
Neurochemical correlates of autistic disorder: a review of the literature.
|
Res Dev Disabil
|
2005
|
1.38
|
|
26
|
Assessing medication effects in the MTA study using neuropsychological outcomes.
|
J Child Psychol Psychiatry
|
2006
|
1.34
|
|
27
|
Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment.
|
J Clin Child Adolesc Psychol
|
2010
|
1.31
|
|
28
|
Reliability of the services for children and adolescents-parent interview.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.31
|
|
29
|
Assessing Homework Problems in Children with ADHD: Validation of a Parent-Report Measure and Evaluation of Homework Performance Patterns.
|
School Ment Health
|
2010
|
1.27
|
|
30
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.
|
J Atten Disord
|
2008
|
1.27
|
|
31
|
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
|
Am J Psychiatry
|
2005
|
1.26
|
|
32
|
Acute and long-term safety and tolerability of risperidone in children with autism.
|
J Child Adolesc Psychopharmacol
|
2005
|
1.24
|
|
33
|
The transition to middle school is associated with changes in the developmental trajectory of ADHD symptomatology in young adolescents with ADHD.
|
J Clin Child Adolesc Psychol
|
2008
|
1.24
|
|
34
|
Socioeconomic status as a moderator of ADHD treatment outcomes.
|
J Am Acad Child Adolesc Psychiatry
|
2002
|
1.23
|
|
35
|
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study.
|
J Clin Psychiatry
|
2012
|
1.23
|
|
36
|
Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.
|
J Child Adolesc Psychopharmacol
|
2003
|
1.23
|
|
37
|
Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder.
|
J Clin Child Adolesc Psychol
|
2011
|
1.20
|
|
38
|
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
|
Biol Psychiatry
|
2006
|
1.18
|
|
39
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.
|
J Atten Disord
|
2008
|
1.18
|
|
40
|
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.
|
Am J Psychiatry
|
2012
|
1.18
|
|
41
|
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
|
J Am Acad Child Adolesc Psychiatry
|
2005
|
1.17
|
|
42
|
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
|
Am J Psychiatry
|
2004
|
1.16
|
|
43
|
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.
|
J Child Adolesc Psychopharmacol
|
2003
|
1.15
|
|
44
|
Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes.
|
J Abnorm Child Psychol
|
2012
|
1.13
|
|
45
|
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors.
|
Lipids
|
2003
|
1.12
|
|
46
|
Time-dependent changes in positively biased self-perceptions of children with attention-deficit/hyperactivity disorder: a developmental psychopathology perspective.
|
Dev Psychopathol
|
2010
|
1.08
|
|
47
|
The treatment of severe child aggression (TOSCA) study: Design challenges.
|
Child Adolesc Psychiatry Ment Health
|
2011
|
1.05
|
|
48
|
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.
|
J Am Acad Child Adolesc Psychiatry
|
2011
|
1.05
|
|
49
|
A review of complementary and alternative treatments for autism spectrum disorders.
|
Autism Res Treat
|
2012
|
1.04
|
|
50
|
A review of neurofeedback treatment for pediatric ADHD.
|
J Atten Disord
|
2011
|
1.03
|
|
51
|
Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders.
|
J Altern Complement Med
|
2012
|
1.03
|
|
52
|
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles.
|
Dev Psychopathol
|
2010
|
1.00
|
|
53
|
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
|
Biol Psychiatry
|
2007
|
1.00
|
|
54
|
Dietary sensitivities and ADHD symptoms: thirty-five years of research.
|
Clin Pediatr (Phila)
|
2010
|
0.99
|
|
55
|
The role of children's ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior.
|
J Consult Clin Psychol
|
2005
|
0.99
|
|
56
|
Examining predictors of reaction times in children with ADHD and normal controls.
|
J Int Neuropsychol Soc
|
2009
|
0.98
|
|
57
|
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder.
|
J Consult Clin Psychol
|
2006
|
0.96
|
|
58
|
A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).
|
Curr Psychiatry Rep
|
2008
|
0.96
|
|
59
|
Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.
|
J Child Adolesc Psychopharmacol
|
2008
|
0.96
|
|
60
|
Treatment for ADHD: is more complex treatment cost-effective for more complex cases?
|
Health Serv Res
|
2007
|
0.96
|
|
61
|
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.
|
J Autism Dev Disord
|
2008
|
0.96
|
|
62
|
Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior.
|
J Emot Behav Disord
|
2010
|
0.95
|
|
63
|
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2010
|
0.94
|
|
64
|
A prospective open trial of guanfacine in children with pervasive developmental disorders.
|
J Child Adolesc Psychopharmacol
|
2006
|
0.94
|
|
65
|
Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.
|
Child Adolesc Psychiatr Clin N Am
|
2014
|
0.94
|
|
66
|
Bipolar and ADHD Comorbidity: Both Artifact and Outgrowth of Shared Mechanisms.
|
Clin Psychol (New York)
|
2010
|
0.94
|
|
67
|
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
|
J Autism Dev Disord
|
2008
|
0.94
|
|
68
|
Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.
|
Child Adolesc Psychiatr Clin N Am
|
2008
|
0.94
|
|
69
|
Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
|
J Atten Disord
|
2008
|
0.93
|
|
70
|
Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder.
|
J Child Adolesc Psychopharmacol
|
2009
|
0.92
|
|
71
|
Research knowledge among parents of children participating in a randomized clinical trial.
|
J Am Acad Child Adolesc Psychiatry
|
2005
|
0.89
|
|
72
|
High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
|
J Child Adolesc Psychopharmacol
|
2012
|
0.89
|
|
73
|
Relation between outcomes on a continuous performance test and ADHD symptoms over time.
|
J Abnorm Child Psychol
|
2011
|
0.88
|
|
74
|
Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.
|
Psychopharmacology (Berl)
|
2006
|
0.88
|
|
75
|
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
|
Child Adolesc Psychiatry Ment Health
|
2009
|
0.88
|
|
76
|
Current status of neurofeedback for attention-deficit/hyperactivity disorder.
|
Curr Psychiatry Rep
|
2012
|
0.87
|
|
77
|
Developmental disabilities modification of the Children's Global Assessment Scale.
|
Biol Psychiatry
|
2007
|
0.86
|
|
78
|
What differentiates children visiting outpatient mental health services with bipolar spectrum disorder from children with other psychiatric diagnoses?
|
Bipolar Disord
|
2012
|
0.86
|
|
79
|
Maternal depressive symptomatology and parenting behavior: exploration of possible mediators.
|
J Abnorm Child Psychol
|
2007
|
0.86
|
|
80
|
Phenomenology of bipolar disorder not otherwise specified in youth: a comparison of clinical characteristics across the spectrum of manic symptoms.
|
Bipolar Disord
|
2013
|
0.86
|
|
81
|
Cognitive effects of risperidone in children with autism and irritable behavior.
|
J Child Adolesc Psychopharmacol
|
2008
|
0.86
|
|
82
|
Empirical evaluation of the generalizability of the sample from the multimodal treatment study for ADHD.
|
Adm Policy Ment Health
|
2006
|
0.86
|
|
83
|
Impact of ADHD and cannabis use on executive functioning in young adults.
|
Drug Alcohol Depend
|
2013
|
0.86
|
|
84
|
Clinical characteristics of children receiving antipsychotic medication.
|
J Child Adolesc Psychopharmacol
|
2011
|
0.86
|
|
85
|
Parents' perceptions of benefit of children's mental health treatment and continued use of services.
|
Psychiatr Serv
|
2012
|
0.85
|
|
86
|
Mental health service use by children with serious emotional and behavioral disturbance: results from the LAMS study.
|
Psychiatr Serv
|
2011
|
0.84
|
|
87
|
Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers.
|
Psychopharmacology (Berl)
|
2007
|
0.83
|
|
88
|
Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.
|
Addiction
|
2015
|
0.83
|
|
89
|
Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.
|
J Child Adolesc Psychopharmacol
|
2010
|
0.83
|
|
90
|
Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials.
|
J Intellect Dev Disabil
|
2009
|
0.83
|
|
91
|
Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.
|
J Child Adolesc Psychopharmacol
|
2015
|
0.83
|
|
92
|
Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
|
J Child Adolesc Psychopharmacol
|
2013
|
0.83
|
|
93
|
Use of outpatient mental health services among children of different ages: are younger children more seriously ill?
|
Psychiatr Serv
|
2014
|
0.82
|
|
94
|
Emotional face processing in pediatric bipolar disorder: evidence for functional impairments in the fusiform gyrus.
|
J Am Acad Child Adolesc Psychiatry
|
2013
|
0.82
|
|
95
|
Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD.
|
Int J Eat Disord
|
2010
|
0.82
|
|
96
|
Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children.
|
Nutr Rev
|
2013
|
0.82
|
|
97
|
Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children.
|
Res Dev Disabil
|
2008
|
0.81
|
|
98
|
Early-onset bipolar spectrum disorders: diagnostic issues.
|
Clin Child Fam Psychol Rev
|
2009
|
0.81
|
|
99
|
Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.
|
J Child Adolesc Psychopharmacol
|
2011
|
0.80
|
|
100
|
Perceived social acceptance and peer status differentially predict adjustment in youth with and without ADHD.
|
J Atten Disord
|
2012
|
0.80
|
|
101
|
Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study?
|
J Consult Clin Psychol
|
2013
|
0.79
|
|
102
|
Prescription of psychiatric medications and polypharmacy in the LAMS cohort.
|
Psychiatr Serv
|
2013
|
0.79
|
|
103
|
Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners.
|
Curr Psychiatry Rep
|
2011
|
0.79
|
|
104
|
Child and parent predictors of perceptions of parent--child relationship quality.
|
J Atten Disord
|
2007
|
0.79
|
|
105
|
Relationship of persistent manic symptoms to the diagnosis of pediatric bipolar spectrum disorders.
|
J Clin Psychiatry
|
2011
|
0.79
|
|
106
|
A systematic review of global publication trends regarding long-term outcomes of ADHD.
|
Front Psychiatry
|
2012
|
0.79
|
|
107
|
Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders.
|
J Dev Phys Disabil
|
2013
|
0.79
|
|
108
|
Discriminating between children with ADHD and classmates using peer variables.
|
J Atten Disord
|
2008
|
0.78
|
|
109
|
Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2015
|
0.77
|
|
110
|
Varenicline in autistic disorder: hypothesis and case report of single-patient crossover.
|
J Child Adolesc Psychopharmacol
|
2013
|
0.77
|
|
111
|
Hallucinations associated with initiation of guanfacine.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
0.77
|
|
112
|
Iron homeostasis during risperidone treatment in children and adolescents.
|
J Clin Psychiatry
|
2015
|
0.77
|
|
113
|
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.
|
J Am Acad Child Adolesc Psychiatry
|
2002
|
0.77
|
|
114
|
Vestibular Stimulation for ADHD: randomized controlled trial of Comprehensive Motion Apparatus.
|
J Atten Disord
|
2008
|
0.77
|
|
115
|
Ethnicity as a moderator of treatment effects on parent--child interaction for children with ADHD.
|
J Atten Disord
|
2009
|
0.77
|
|
116
|
Fish oil is not snake oil.
|
J Am Acad Child Adolesc Psychiatry
|
2011
|
0.76
|
|
117
|
Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders.
|
J Child Adolesc Psychopharmacol
|
2013
|
0.75
|
|
118
|
Diagnosing and managing complicated ADHD.
|
Prim Care Companion J Clin Psychiatry
|
2008
|
0.75
|
|
119
|
Antipsychotics for aggressive behavior in patients with intellectual disability--an acceptable standard of care?
|
Nat Clin Pract Neurol
|
2008
|
0.75
|
|
120
|
Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.
|
J Abnorm Child Psychol
|
2002
|
0.75
|
|
121
|
Solving the puzzle of attention deficit hyperactivity disorder.
|
Nutr Rev
|
2011
|
0.75
|
|
122
|
Diagnosing and managing complicated ADHD.
|
J Clin Psychiatry
|
2007
|
0.75
|
|
123
|
Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
|
J Clin Psychopharmacol
|
2005
|
0.75
|
|
124
|
Assessing change in core autism symptoms: challenges for pharmacological studies.
|
J Child Adolesc Psychopharmacol
|
2015
|
0.75
|
|
125
|
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13 Month Follow-up.
|
J Am Acad Child Adolesc Psychiatry
|
2020
|
0.75
|